A Study of the Role of Antiplatelet Therapy in the Prevention of Thrombosis in Patients with Calr-Mutated Low Risk Essential Thrombocythemia
Alberto Álvarez‐Larrán(Hospital Clínic de Barcelona), Carlos Besses(Hospital Del Mar), Martin Grießhammer(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie), Samah Alimam(University College Hospital), Paola Guglielmelli(Azienda Ospedaliero-Universitaria Careggi), Francisco Cervantes(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Eduardo Arellano‐Rodrigo(Vall d'Hebron Hospital Universitari), Valentín García‐Gutiérrez(Universidad de Alcalá), Pere Barba(Universitat Autònoma de Barcelona), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Ana Kerguelen(Hospital Universitario La Paz), Jan Samuelsson(Karolinska University Hospital), Radek C. Skoda(University Hospital of Basel), Björn Andréasson(NU Hospital Group), Stefanie Slot(Amsterdam UMC Location Vrije Universiteit Amsterdam), Yan Beauverd(St Thomas' Hospital), Juan Carlos Hernández‐Boluda(Hospital Clínico Universitario de Valencia), Chiara Paoli(University of Genoa), Carmen Burgaleta(Universidad de Alcalá), Rosa Ayala(Hospital Universitario 12 De Octubre), María Teresa Gómez‐Casares(Universidad de Las Palmas de Gran Canaria), Jiřı́ Schwarz(University Hospital Brno), Francisca Ferrer‐Marín(Centre for Biomedical Network Research on Rare Diseases)
Cited by 2
Related Papers
A Gain-of-Function Mutation of <i>JAK2</i> in Myeloproliferative Disorders
|New England Journal of Medicine|2005|3.5k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
|Blood|2014|722
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540